ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,416,004, issued on Sept. 16, was assigned to Sanofi (Paris).
"RNA compositions and methods for inhibiting ANGPTL8" was invented by Bodo Brunner (Frankfurt am Main, Germany), Mike Helms (Frankfurt am Main, Germany), Armin Hofmeister (Frankfurt am Main, Germany), Kerstin Jahn-Hofmann (Frankfurt am Main, Germany), Christiane Metz-Weidmann (Frankfurt am Main, Germany), Sabine Scheidler (Frankfurt am Main, Germany) and Pierrick Rival (Paris).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to dsRNAs targeting ANGPTL8, methods of inhibiting ANGPTL8 gene expression, and methods of treating one or more conditions associated with ANG...